Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Sacubitril/valsartan vs ACEI/ARB in acute decompensated chronic heart failure
ChiCTR2100046851Phase 4Completed
- Sponsor
- The First Affiliated Hospital of Harbin Medical University
- Start
- Oct 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4 trial of sacubitril + valsartan in heart failure (HF) (2 arms), sponsored by The First Affiliated Hospital of Harbin Medical University. Primary endpoint: death from cardiovascular causes. Started Oct 2017; status: completed.
02
Drugs
sacubitril + valsartan
03
Conditions
heart failure (HF)
Beyond the preview
Go deeper on ChiCTR2100046851.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2100046851.